These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

238 related articles for article (PubMed ID: 21397983)

  • 1. Quality of life in cutaneous lupus erythematosus.
    Klein R; Moghadam-Kia S; Taylor L; Coley C; Okawa J; LoMonico J; Chren MM; Werth VP
    J Am Acad Dermatol; 2011 May; 64(5):849-58. PubMed ID: 21397983
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Differences in quality of life in patients with cutaneous lupus erythematosus with varying income levels.
    Joseph A; Prasad S; Hynan LS; Chren MM; Chong B
    Lupus; 2021 May; 30(6):972-980. PubMed ID: 33663251
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A multicentre, cross-sectional study on quality of life in patients with cutaneous lupus erythematosus.
    Vasquez R; Wang D; Tran QP; Adams-Huet B; Chren MM; Costner MI; Cohen JB; Werth VP; Chong BF
    Br J Dermatol; 2013 Jan; 168(1):145-53. PubMed ID: 22708924
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prevalence of self-report photosensitivity in cutaneous lupus erythematosus.
    Foering K; Goreshi R; Klein R; Okawa J; Rose M; Cucchiara A; Werth VP
    J Am Acad Dermatol; 2012 Feb; 66(2):220-8. PubMed ID: 21742409
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evaluation of the quality of life of lupus erythematosus patients with cutaneous lesions in Japan.
    Ishiguro M; Hashizume H; Ikeda T; Yamamoto Y; Furukawa F
    Lupus; 2014; 23(1):93-101. PubMed ID: 24197553
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Validation of the Cutaneous Lupus Disease Area and Severity Index (CLASI) using physician- and patient-assessed health outcome measures.
    Jolly M; Kazmi N; Mikolaitis RA; Sequeira W; Block JA
    J Am Acad Dermatol; 2013 Apr; 68(4):618-623. PubMed ID: 23107310
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Factors associated with quality of life in cutaneous lupus erythematosus using the Revised Wilson and Cleary Model.
    Ogunsanya ME; Cho SK; Hudson A; Chong BF
    Lupus; 2020 Nov; 29(13):1691-1703. PubMed ID: 32883161
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A quality-of-life study of cutaneous lupus erythematosus.
    Batalla A; García-Doval I; Peón G; de la Torre C
    Actas Dermosifiliogr; 2013 Nov; 104(9):800-6. PubMed ID: 23787361
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Chronic Cutaneous Lupus Erythematosus: Depression Burden and Associated Factors.
    Hong J; Aspey L; Bao G; Haynes T; Lim SS; Drenkard C
    Am J Clin Dermatol; 2019 Jun; 20(3):465-475. PubMed ID: 30877492
    [TBL] [Abstract][Full Text] [Related]  

  • 10. How does quality of life of patients with systemic lupus erythematosus compare with that of other common chronic illnesses?
    Jolly M
    J Rheumatol; 2005 Sep; 32(9):1706-8. PubMed ID: 16142864
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The impact of skin damage due to cutaneous lupus on quality of life.
    Verma SM; Okawa J; Propert KJ; Werth VP
    Br J Dermatol; 2014 Feb; 170(2):315-21. PubMed ID: 24111880
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Impact of smoking in cutaneous lupus erythematosus.
    Piette EW; Foering KP; Chang AY; Okawa J; Ten Have TR; Feng R; Werth VP
    Arch Dermatol; 2012 Mar; 148(3):317-22. PubMed ID: 22105815
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cross-sectional analysis of a collaborative Web-based database for lupus erythematosus-associated skin lesions: prospective enrollment of 114 patients.
    Moghadam-Kia S; Chilek K; Gaines E; Costner M; Rose ME; Okawa J; Werth VP
    Arch Dermatol; 2009 Mar; 145(3):255-60. PubMed ID: 19289753
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A systematic review of patient-reported outcomes in patients with cutaneous lupus erythematosus.
    Ogunsanya ME; Kalb SJ; Kabaria A; Chen S
    Br J Dermatol; 2017 Jan; 176(1):52-61. PubMed ID: 27416958
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The study of Cutaneous Lupus Erythematosus Disease Area and Severity Index in Indian patients with systemic lupus erythematosus.
    Salphale P; Danda D; Chandrashekar L; Peter D; Jayaseeli N; George R
    Lupus; 2011 Dec; 20(14):1510-7. PubMed ID: 21997966
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pain and pruritus in cutaneous lupus: their association with dermatologic quality of life and disease activity.
    Méndez-Flores S; Orozco-Topete R; Bermúdez-Bermejo P; Hernández-Molina G
    Clin Exp Rheumatol; 2013; 31(6):940-2. PubMed ID: 23981524
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The cutaneous lupus erythematosus disease area and severity index: a responsive instrument to measure activity and damage in patients with cutaneous lupus erythematosus.
    Bonilla-Martinez ZL; Albrecht J; Troxel AB; Taylor L; Okawa J; Dulay S; Werth VP
    Arch Dermatol; 2008 Feb; 144(2):173-80. PubMed ID: 18283174
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cutaneous, systemic features and laboratory characteristics of late- versus adult-onset systemic lupus erythematosus in 1006 Thai patients.
    Chanprapaph K; Tubtieng I; Pratumchat N; Thadanipon K; Rattanakaemakorn P; Suchonwanit P
    Lupus; 2021 Apr; 30(5):785-794. PubMed ID: 33554715
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cutaneous lupus erythematosus: quality of life and related factors in a cohort of 260 patients from A Coruña, Spain.
    Arévalo-Bermúdez MP; Pita-Fernández S; Paradela S; Fonseca E
    Br J Dermatol; 2018 Feb; 178(2):e117-e118. PubMed ID: 28832955
    [No Abstract]   [Full Text] [Related]  

  • 20. Evaluating change in disease activity needed to reflect meaningful improvement in quality of life for clinical trials in cutaneous lupus erythematosus.
    Chakka S; Krain RL; Ahmed S; Concha JSS; Feng R; Merrill JT; Werth VP
    J Am Acad Dermatol; 2021 Jun; 84(6):1562-1567. PubMed ID: 32682879
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.